A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents, and young adults with relapsed or refractory osteosarcoma (OLIE; ITCC-082) Meeting Abstract
| Authors: | Gaspar, N.; Campbell-Hewson, Q.; Bielack, S. S.; Campbell, M.; Bautista, F.; Meazza, C.; Janeway, K.; Dela Cruz, F. S.; Whittle, S.; Morgenstern, D. A.; Dutta, L.; McKenzie, J.; O'Hara, K.; Huang, J.; Okpara, C. E.; Bidadi, B.; Koh, K. N.; Moreland, B. |
| Abstract Title: | A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents, and young adults with relapsed or refractory osteosarcoma (OLIE; ITCC-082) |
| Meeting Title: | ESMO Asia Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2020 Nov 20-22 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | S1414 |
| End Page: | S1415 |
| Language: | English |
| ACCESSION: | WOS:000600988900446 |
| DOI: | 10.1016/j.annonc.2020.10.435 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 443TiP -- Source: Wos |
